Kristin Gingrich, DPM
Podiatrist · Glen Allen, VANPI 1164489837
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,462 of the $2,212 with a category attached, or 66.1%. 8 manufacturers reported payments, led by Arbor Pharmaceuticals, Inc. at 49.2% of the total. Reporting peaked in 2022 at $1,228 and has fallen 98.9% since, to $13 in 2024.
Across 194 payments — averaging $11.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arbor Pharmaceuticals, Inc.$1K
- IBSA Pharma Inc.$831
- Azurity Pharmaceuticals, Inc.$156
- GRT US Holding, Inc.$79
- Stryker$16
- Pfizer$15
- plus $27 from 2 others
What the payments were for
- Consulting fees$75034%
- Food & beverage$1,46266%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arbor Pharmaceuticals, Inc. | 142 | $1,088 |
| IBSA Pharma Inc. | 16 | $831 |
| Azurity Pharmaceuticals, Inc. | 16 | $156 |
| GRT US Holding, Inc. | 16 | $79 |
| Stryker | 1 | $16 |
| Pfizer | 1 | $15 |
| Averitas Pharma Inc. | 1 | $14 |
| Organogenesis Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,212 in reported general payments places this provider in the 65th percentile of 126 podiatrist providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluconazole | 121 | $3,793 |
| Gabapentin | 213 | $3,102 |
| Pregabalin | 104 | $2,895 |
| Duloxetine Hcl | 68 | $2,061 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 34 | $1,616 |
| Fentanyl | 11 | $1,554 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 31 | $787 |
| Celecoxib | 26 | $655 |
| Nortriptyline Hcl | 44 | $647 |
| Allopurinol | 64 | $428 |
| Diclofenac Sodium | 18 | $285 |
| Terbinafine Hcl | 41 | $253 |
| Tramadol Hcl | 14 | $245 |
| Hydromorphone Hcl | 11 | $207 |
| Vitamin D2Ergocalciferol (Vitamin D2) | 17 | $186 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Glen Allen
- John ClementsRoanoke$925K
- Leland GilmoreAlexandria$155K
- Justin PhillinganePetersburg$82K
- Jeremy WaltersSuffolk$60K
- Matthew HopsonWilliamsburg$44K
- Benjamin ProtoNewport News$26K
- Kevin RabieVirginia Beach$18K
- Nelson KellerGrafton$17K
- Robert BoguskiRoanoke$12K
- Stacie BuckNewport News$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.